Loading insider details...
Beta
Latest Form 4 (Jan 13, 2026): Grant/Award of 30,456 LSTA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 13, 2026 | LISATA THERAPEUTICS, INC. (LSTA) | Grant/Award | 30,456 | n/a |
| Jan 13, 2025 | LISATA THERAPEUTICS, INC. (LSTA) | Grant/Award | 15,789 | n/a |
| Sep 27, 2024 | DURECT CORP (DRRX) | Grant/Award | 5,500 | n/a |
| Jan 11, 2024 | LISATA THERAPEUTICS, INC. (LSTA) | Grant/Award | 19,480 | n/a |
| Dec 20, 2023 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 823 | $8.1K |
| Jun 2, 2023 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 18,475 | n/a |
| Jan 11, 2023 | LISATA THERAPEUTICS, INC. (LSTA) | Grant/Award | 20,000 | n/a |
| Dec 13, 2022 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 3,086 | $8.3K |
| Sep 16, 2022 | LISATA THERAPEUTICS, INC. (LSTA) | Grant/Award | 19,200 | $120.0K |
| Jun 29, 2022 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 18,000 | n/a |